Farah
Virtuosa
- Intent: To create a disaster of a drug that imparts Force sensitivity.
- Image Source: Beth, also reverse image search wouldn’t give me a source so.
- Restricted Missions: N/A
- Primary Source: N/A
- Name: Midi-Synth
- Manufacturer: Cornerstone Scientific
- Homeworld (optional): N/A
- Production: Semi-Unique
- Affiliation: Closed Market [Thread may be required to obtain]
- Modularity: N/A
- Legal Status: Unregistered, not sold commercially, probably really illegal
- Ingredients: Midichlorian extract, drug fillers
- Classification: Drug
- Method of Consumption: Intravenous
- Average Life: 6~12 months
- Nutritional Value/Allergies/Side Effects/ Purpose:Purpose: Imparts Force sensitivity into sentients
- Side effects (expanded on in weaknesses and description):
- Short term:
- Exhaustion
- Anxiety
- Skin hypersensitivity
- Nausea and general stomach upset
- Chills
- Fever
- Anxiety
- Increased appetite
- Varying levels of mental instability
- Nightmares
- Psychosis
- Violent tendencies
- Radical personality change
- Death
[/list]
SPECIAL FEATURES
- Increases Force sensitivity
- Grants non-Force sensitive subjects sensitivity to the Force.
- Increases midichlorian count and relative Force sensitivity of those who are already Force sensitive.
- Fatal in 10% of cases.
- Ineffective in 10% of cases.
- Partially effective in 20% of cases.
- Has severe long term side effects that some have considered “totally not worth it”.
- Takes 2-3 weeks of painful circumstances to take effect.
- Temporary (6~12 month duration).
Midi-Synth is first and foremost an experimental drug created as a vanity projected for Farah and less for retail. It is not sold commercially and not advertised by Cornerstone Scientific, rather the production of the drug is kept relatively silent. It is not sold commercially and is currently only in use at Cornerstone approved facilities. Obtaining Midi-Synth is difficult as Farah herself keeps close tabs on every lot that is produced and sells it sparingly to others. Several trials have been conducted by Farah on humanoid subjects to see how the drug is tolerated and to get a better understanding of Midi-Synth’s side effects.
Midi-Synth is, essentially, a disastrous sort of success. The primary ingredient of this drug is an extract derived from Farah’s own midichlorians as well as the blood samples of a few other Force sensitives. It takes roughly 1.5-2.0 pints (0.7-1 liter) of blood to produce one batch of the drug (6 doses) and thus blood transfusions may be necessary after specimen extraction. Midi-Synth is created by isolating midichlorians in blood specimens, separating them out and mixing them with a cocktail of molecular fillers. Once complete, the shelf life of this drug is ~3 months when kept in optimal conditions which include being incubated at ambient humanoid body temperature and CO2 levels. The drug weakens in effect from 3-6 months before it plateaus to be largely ineffective after 6 months. The potency of Midi-Synth can shorten if the drug is not kept in optimal storage conditions.
[OOC DISCLAIMER: This drug cannot be used to justify extreme displays of the Force. For Force sensitives, this drug grants a small yet noticeable bump in Force sensitivity. Please see the table under 'Properties' which determines how relative bumps in Force ability work]
TAKING EFFECT
For the drug to take full effect, 25~40ccs must be administered intravenously depending on the subject’s size and race. Particularly large races, abnormally large humanoids and species that metabolize drugs quickly generally need a larger quantity of Midi-Synth for it to become effective. Midi-Synth has two phases: Transformative and Recovery.
- Transformative Phase:Once injected, it takes roughly 1~3 hours for the drug to begin to take effect. During this time the subject may find themselves feeling generally unwell and may spike a fever and/or begin to get chills. Rolling nausea, dry mouth and eyes, hypersensitivity of the skin and heightened anxiety may also occur. These symptoms are caused by midichlorians entering the subject’s bloodstream and increase gradually in intensity until they reach their peak after about 4~5 hours after the drug has started to take effect. During this peak, subjects may require restraint as the pain has been described as being an “incredibly intense swelling of the bones from the inside out”. The pain has also been described as a searing ache emanating from the core outwards to the extremities. This pain is caused by the body’s immune system seeking to destroy the invading midichlorians which are seen as a foreign intruder. As such, immunosuppressive drugs must be given in order to lessen the body’s natural response to destroy the midichlorians. This often weakens the subject and makes them susceptible to secondary infections so it is imperative that the subject be treated with this drug in a sterile, supervised environment.
- After the initial Transformative Phase, a subject may take up to two weeks to recover and regain their full strength. During the Recovery Phase, subjects are monitored closely with daily labs to test their midichlorian counts and basic metabolic functions. Immunosuppressants are gradually tapered off as the subject regains strength and their midichlorian count rises. Subjects are examined daily for any signs of disease—if found, they are treated as quickly and as efficiently as possible.
If intravenous injection of Midi-Synth is successful, the subject will find themselves with the ability to use the Force. However, this new ability comes with a lot of caveats and unwanted side effects.
- Properties:
- Only neutral and dark side abilities can be picked up. To date, no successful course of Midi-Synth has produced a subject capable of light sided abilities.
- The Force potential gained from Midi-Synth tends to be of average/Knight level regardless of who the initial midichlorians are taken from. This is largely due to the fact that each batch of Midi-Synth contains the same number of midichlorians, a concentration determined to be tolerable to a wider range of subjects.
- Side Effects:
- Initial side effects from the Transformative and Recovery phases are short term and will not last longer than two weeks. These side effects include fever, nausea, chills, upset stomach and/or dry mouth/eyes.
- Long term side effects can vary from individual to individual as well as range in intensity. So far these have included anxiety, increase in appetite, mental instability, nightmares, psychosis, violent tendencies, mood swings and personality change.
- If a subject survives the initial phases, they are still subject to intense side effects which may lead to death. So far, two subjects in Farah’s trail have died due to mental deterioration and psychosis. These side effects can extend for the duration of the drug’s affect (6~12 months).
- Death occurs in about 10% of subjects during the Transformative and Recovery phases. About 5% die in the Transformative phase due to a rapid increased immune system response leading to widespread organ failure. Roughly 5% of all trial subjects die during the Recovery Phase either from the immune response of their body rejecting the midichlorians or a secondary infection.
- Out of all subjects, 10% do not show any signs of Force sensitivity. These subjects exhibit similar reactions to successful subjects during the Transformative and Recovery phase but ultimately cannot sustain the midichlorians in their blood.
- Out of all subjects, 20% do not absorb the maximum concentration of the drug and exhibit a lesser affinity for the Force than successful subjects (comparable to apprentice and below level).
- As Midi-Synth is a relatively new drug only tested on a small sample size, the full extent of its side effects are unknown at this time.
It is important to note that while Midi-Synth allows a subject sensitivity to the Force for a limited time, it does not grant the immediate use of specific Force abilities. Like all Force sensitives natural or not, those under the influence of Midi-Synth must undergo training in order to develop Force abilities. Most subjects who’ve successfully Subjects who’ve undergone a successful round of Midi-Synth should have midichlorian counts taken regularly. Once they begin to decline, a subject can be injected with a supplemental low dose of the drug in order to maintain Force sensitivity. This second, lower dose often has less severe side effects than the first dose. If the drug is allowed to wear off entirely, the subject will be left feeling drained for several weeks before recovering to full health.
If a subject who is naturally Force sensitive takes this drug, they may develop a heightened midichlorian count and notice an increase in their affinity for the Force. This increase will be substantial in the sense that it will give a small yet noticeable increase in Force ability. For example, a high level Apprentice will be bumped up to low level Knight ability while under the influence of a single dose of Midi-Synth. The effects of Midi-Synth on Force ability are outlined in the table below. Please note that the effects of Midi-Synth begin to exponentially plateau the stronger an individual's Force ability is. This information is not yet known ICly.
The mechanisms for the slight increase in Force ability (compared to a non Force sensitive obtaining Knight level Force affinity) are not well understood, though it is theorized that this is due to the synthetic midichlorians being genetically different than those that already inhabit a Force user's body. They are still susceptible to experiencing the same side effects as anyone else but generally have shorter, easier Transformative and Recovery phases. The length and intensity of these phases is scaled to the dosage taken; smaller doses are easier to tolerate than larger ones. This result should be interpreted with caution as the sample size is a single Force sensitive overzealous Zeltron.
Force-dead individuals who take this drug will likely not gain any level of Force sensitivity, though they may experience similar symptoms as a non-Force user as their body rejects the drug. There is also the possibility that they may not outright reject the drug, but that the midichlorians will die off naturally as they have cannot sustain themselves via a symbiotic relationship with their host. In theory it may be possible, with genetic modification, for a Force dead individual to gain Force sensitivity through the use of Midi-Synth after being altered to accept midichlorians. However, no trials have been conduced with Force dead individuals so this information is unknown ICly.
Out of all the side effects of Midi-Synth, one that occurs across the board in all successful subjects is an increase in appetite. It has been theorized that this is due to addition of the midichlorians, a foreign microorganism that requires energy to function though the mechanisms of this are not well understood.
Midi-Synth is not a well-known drug and many Cornerstone Scientific employees are unaware of its existence. A personal meeting with Farah is required to obtain it (unless stolen) and professional monitoring at a capable facility is recommended.
